Summary: HCV Testing and Treatment in Correctional Settings
Recommendations for Screening and Treatment of HCV Infection in Jails
|
|
RECOMMENDED
|
RATING 
|
Jails should implement opt-out HCV testing consisting of HCV-antibody testing followed by confirmatory HCV-RNA testing if antibody-positive.
-
Chronically infected individuals should receive counseling about HCV infection and be provided linkage to follow-up community healthcare for evaluation of liver disease and treatment upon release.
-
Chronically infected individuals whose jail sentence is sufficiently long to complete a recommended course of antiviral therapy should receive treatment for chronic HCV infection according to AASLD/IDSA guidance while incarcerated. Upon release, patients should be provided linkage to community healthcare for surveillance for HCV-related complications.
|
IIa, C
|
Recommendations for Screening and Treatment of HCV Infection in Prisons
|
|
RECOMMENDED
|
RATING
|
|
Prisons should implement opt-out HCV testing. Chronically infected individuals should receive antiviral therapy according to AASLD/IDSA guidance while incarcerated. Upon release, patients should be provided linkage to community healthcare for surveillance for HCV-related complications.
|
IIa, C
|
|
To prevent HCV reinfection and reduce the risk of progression of HCV-associated liver disease, prisons should provide harm reduction and evidence-based treatment for underlying substance use disorders.
|
IIa, C
|
Recommendation for Continuation of HCV Treatment in Jail and Prison Settings
|
|
RECOMMENDED
|
RATING
|
|
Jails and prisons should facilitate continuation of HCV therapy for individuals on treatment at the time of incarceration.
|
IIa, C
|
